Pharma & Biotech

Pharmaceutical companies, biotech startups, drug approvals, and healthcare industry news.

Daily Indian Funding Roundup & Key News - 12 February 2026

Daily Indian Funding Roundup & Key News - 12 February 2026: Elixiir Foods Raises $9M, Indigrid Tech Secures ₹40 Cr, USV Pharma-Wellbeing Nutrition Deal & More

The Indian startup landscape saw diverse funding across grocery tech, deep tech, sustainable materials, electronics manufacturing, and sleep and dining technologies on 12 Feb 2026. Elixiir Foods raised a $9 million seed round to build a destination-led tech-driven grocery platform, while Indigrid Technology attracted ₹40 crore in Series A funding

By StartupTalky News
Pandorum Technologies Raises US$18 Million in Series B to Advance Global Access to Programmable Tissue Regenerative Therapies

Pandorum Technologies Raises US$18 Million in Series B to Advance Global Access to Programmable Tissue Regenerative Therapies

Pandorum Technologies, a biotechnology company pioneering programmable regenerative medicine, with operations in India and the United States, has announced the closing of  a US$18 million in Series B financing round, to advance the clinical development of its disease-modifying, tunable, exosome-based therapies, including Kuragenx, while scaling global manufacturing and expanding

By Shubham Kumar
Mankind Pharma’s Rajeev Juneja Headlines Nutrify Today’s ‘Legends of Lifesciences’ Series; Advocates for the ‘Pharmaceuticalization’ of Wellness

Mankind Pharma’s Rajeev Juneja Headlines Nutrify Today’s ‘Legends of Lifesciences’ Series; Advocates for the ‘Pharmaceuticalization’ of Wellness

Nutrify Today, the global catalyst for the nutraceutical industry, has premiered a landmark feature in its documentary series, Legends of Lifesciences, featuring Rajeev Juneja, Vice Chairman and Managing Director of Mankind Pharma. The documentary offers a rare, high-level perspective on the evolution of Indian healthcare, chronicling Juneja’s journey from

By Shubham Kumar
Navy Vijay Ramavat, MD of Indira Securities

📰 News

Navy Vijay Ramavat on Navigating Market Cycles and Powering Investment Opportunities through Indira Securities

In this exclusive interaction with StartupTalky, Navy Vijay Ramavat, Managing Director of Indira Securities, shares his insights on reading market signals, navigating volatility, and spotting opportunities amid changing global and domestic trends. He discusses how investors can balance active and passive strategies, benefit from emerging sectors like pharma, engineering, textiles,

By Sanvi Barjatya
Dr. Bushra Sumra, A Dedicated Medical Doctor

Innovative Approaches to Asthma Research: Leveraging Data from Clinical Trials Insights From Bushra Sumra

Asthma research is undergoing a groundbreaking transformation, marked by innovative approaches that harness the power of data derived from clinical trials to advance our understanding and management of this complex condition. By utilizing advanced statistical tools and technologies, researchers are delving deeper into the nuances of asthma, uncovering insights that

By Subham Kumar
Emcure Pharmaceuticals: India's 11th Largest Pharmaceutical Company

👨‍💻 StartupTalkers

Emcure Pharmaceuticals: India's 11th Largest Pharmaceutical Company

In the essential realm of healthcare, the pharmaceutical industry stands as a beacon of progress, vital for global well-being and economic prosperity. Pharmaceutical companies are closely inspected to guarantee the manufacturing of high-quality medications since they operate at the intersection of innovation and responsibility. Governments, realizing how vital health is,

By Shalini Rath, Apoorva Bajj
Addressing Pricing Challenges: Balancing Affordability and Profitability in Specialty Medicine Sales

📚 Learning

How to Address Pricing Challenges: Balancing Affordability and Profitability in Specialty Medicine Sales

This article has been contributed by Devashish Singh, Co-Founder, MrMed. The largest pharmaceutical companies are engaged in researching and developing therapies for super speciality diseases such as cancer, Alzheimer’s, osteoarthritis and other chronic conditions that are relatively rare and extremely complex. Cancer, for example, has various stages and medications

By Subham Kumar
Dr. Reddy's Success Story

👨‍💻 StartupTalkers

Dr. Reddy’s Laboratories Success Story | How Does This Pharma Company Plans to Lead the Indian Market?

Company Profile is an initiative by StartupTalky to publish verified information on different startups and organizations. To talk about pharma and medicines in today's times, the industry is considered one of the most booming industries. These industries have offered a prevalence of contributions to the world of medicine.

By Shalini Rath, Manisha Mishra